A carregar...
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era
Chemotherapy-induced damage of hematopoietic stem and progenitor cells (HPSCs) often results in myelosuppression that adversely affects patient health and quality of life. Currently, chemotherapy-induced myelosuppression is managed with chemotherapy dose delays/reductions and lineage-specific suppor...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8299941/ https://ncbi.nlm.nih.gov/pubmed/34307165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.697908 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|